Soligenix, Inc Stock News

Soligenix (NASDAQ:SNGX) shares surged more than 44% after the biopharmaceutical company won Orphan Drug Designation from US regulators for the active ingredient in its MarVax vaccine for Marburg Marbu

Stocks are up today and investors wondering what's behind that rally have come to the right place as we have the latest news for Monday! Stocks are up today as retail data came in better than expected

Soligenix (NASDAQ: SNGX ) stock is rocketing higher on Monday after getting an orphan drug designation for the active ingredient in MarVax. This comes from the Food and Drug Administration's (FDA) Off

PRINCETON, N.J. , Jan. 25, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to

Soligenix (NASDAQ:SNGX) shares added almost 35% before the opening bell on Tuesday after it revealed its novel vaccine provided 100% protection against two deadly infections in non-human primate model

Soligenix (NASDAQ: SNGX ) stock is on the rise Thursday after the company got approval from the Food and Drug Administration for a Phase 2a clinical trial of SGX945. According to a press release from

Soligenix (NASDAQ:SNGX) shares more than doubled on Thursday after the biopharmaceutical company announced positive results from a compatibility study of its investigational therapeutic HyBryte in cut

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 50 points on Tuesday. The Dow traded down 0.16% to 34,191.46 while the NASDAQ rose 0.51% to 11,952.38. The

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users. Boxlight Corporation (NASDAQ: BOXL

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 250 points on Tuesday. The Dow traded down 0.79% to 33,975.65 while the NASDAQ fell 0.59% to 11,821.20. The S&P 5

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42

Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares rose 38.3% to $1.62 in pre-market trading. Blue Water Vaccines recently appointed Frank Jaeger, seasoned commercial operations and business deve

Soligenix (NASDAQ:SNGX) slumped in Tuesday's early deals after revealing its cancer drug has been knocked back by the US Food and Drug Administration. The company, in a statement, told investors that

Focusing on 25 micro-cap companies with key catalysts and/or strong performance in the current market PRINCETON, N.J. , Jan. 19, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C. 180 Life Scien